NVO P/B: current value, 10-year range and year-by-year history
Cash & Leverage
NVO's p/b is lower than 95% of the last 10 years.
P/B History
NVO P/B by year
Yearly range of NVO’s p/b from 2016 to 2026. Over the full period it ranged from 5.2 to 279.2, averaging 71.3.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 5.2 | 6.4 | 9.2 | 5.7 |
| 2025 | 7.4 | 12.7 | 20.3 | 7.4 |
| 2024 | 19.3 | 88.7 | 279.2 | 19.3 |
| 2023 | 24.5 | 171.6 | 247.2 | 237.6 |
| 2022 | 20.0 | 142.2 | 212.3 | 211.8 |
| 2021 | 23.8 | 127.4 | 171.3 | 23.8 |
| 2020 | 94.8 | 113.8 | 133.0 | 95.3 |
| 2019 | 14.2 | 16.3 | 105.8 | 105.8 |
| 2018 | 13.7 | 15.9 | 18.5 | 14.0 |
| 2017 | 11.7 | 15.0 | 18.1 | 18.1 |
| 2016 | 12.4 | 14.8 | 17.6 | 14.0 |
Get notified when NVO P/B crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
How much the market pays relative to the company's accounting net worth (assets minus liabilities). P/B < 1 means the market values the company below what the books say it owns.
Price / Book Value Per ShareMost useful for asset-heavy businesses: banks, insurers, REITs. A P/B near its historical low suggests the market is paying unusually little for the net assets.
- Goodwill and intangibles from acquisitions can inflate book value significantly — some analysts prefer tangible book value.
- Low P/B in technology or software companies is usually irrelevant: their value is in IP and people, not balance sheet assets.
Is NVO P/B High or Low Right Now?
Novo Nordisk A/S's P/B is currently 5.7, which is near historic low relative to its 10-year historical range. The 10-year median P/B for NVO is approximately 22.4. See all NVO valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.